Sales and EBITDA remained stable in H1 2026, with improved margins and strong cash flow. Perlen Packaging outperformed, while Zeochem faced margin pressure. The group raised its dividend payout ratio and expects slightly higher full-year sales and EBITDA.Original document: CPH Group AG Class A [CPH…
Sales and EBITDA remained stable in H1 2026, with improved margins and strong cash flow. Perlen Packaging outperformed, while Zeochem faced margin pressure. The group raised its dividend payout ratio and expects slightly higher full-year sales and EBITDA.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.